Monday 27 June 2011

Drug firms 'too heavily reliant on ageing sales portfolios'

"Last year, drug sales were at an all-time high of $856bn (£535bn), but only 5pc of those sales were driven by products launched within the last five years. The struggle companies face in reinvigorating their portfolios was illustrated by the number of "new molecular entities" launched last year dropping to 21, down from 26 in 2009. "

http://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/8599643/Drug-firms-too-heavily-reliant-on-ageing-sales-portfolios.html

No comments:

Post a Comment

The lowcarb team value your comments. Thank you for taking the time to contribute to our blog. Please note! negative comments and insults from anonymous idiots, with nothing to add to the debate will not be authorised. However, we welcome constructive criticism.

The best of health to you and yours.

Eddie